Avanir posts mixed late stage Zenvia study results

ALISO VIEJO, Calif. — Avanir Pharmaceuticals Inc. on Friday reported mixed results for its drug candidate Zenvia, which is intended to reduce involuntary emotional outbursts in patients [...]

• Caroline says: This drug is being studied in other neurological disorders in addition to MS. There are no currently approved treatments for pseudobulbar effect (uncontrolled crying or laughing) for any neurological condition.